Cargando…
Treatment of stage 4s neuroblastoma – report of 10 years' experience of the French Society of Paediatric Oncology (SFOP)
Stage 4s neuroblastoma (NB) is usually associated with a favourable outcome, despite a large tumour burden, as spontaneous regression frequently occurs. However, in some infants rapid disease progression can be observed with severe functional impairment. Thus, for all patients the potential risks of...
Autores principales: | Schleiermacher, G, Rubie, H, Hartmann, O, Bergeron, C, Chastagner, P, Mechinaud, F, Michon, J |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2003
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2394373/ https://www.ncbi.nlm.nih.gov/pubmed/12888814 http://dx.doi.org/10.1038/sj.bjc.6601154 |
Ejemplares similares
-
Adverse outcome of infants with metastatic neuroblastoma, MYCN amplification and/or bone lesions: results of the French Society of Pediatric Oncology
por: Minard, V, et al.
Publicado: (2000) -
Combined treatment modality for intracranial germinomas: results of a multicentre SFOP experience
por: Bouffet, E, et al.
Publicado: (1999) -
Localised and unresectable neuroblastoma in infants: excellent outcome with low-dose primary chemotherapy
por: Rubie, H, et al.
Publicado: (2003) -
Unresectable localized neuroblastoma: improved survival after primary chemotherapy including carboplatin-etoposide. Neuroblastoma Study Group of the Société Française d'Oncologie Pédiatrique (SFOP).
por: Rubie, H., et al.
Publicado: (1998) -
Prognostic factors in localized Ewing's tumours and peripheral neuroectodermal tumours: the third study of the French Society of Paediatric Oncology (EW88 study)
por: Oberlin, O, et al.
Publicado: (2001)